A study of effective dietary therapy to control of hyperphosphatemia

Completed

• Conditions: Hyperphosphatemia; Nutritional, Metabolic, Endocrine; Disorders of phosphorus metabolism and phosphatases

• Registration Number: ISRCTN13160049
• Lead Sponsor: niversity of Shizuoka (Japan)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-06
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 14

Inclusion Criteria

1. 20-40 years old
2. Male

Exclusion Criteria

1. Smoking
2. History or medication use for glucose tolerance, renal or hepatic dysfunction

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum phosphorus level, measured at baseline (0 hours) and 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 24.0 hours after

Secondary Outcome Measures

Name	Time	Method
1. Urinary phosphorus excretion, measured at four times over the 24 hours: between 07:30 h to 12:30 h (morning); 12:30 h to 17:30 h (afternoon); 17:30 h to 22:30 h (evening); and 22:30 h to 07:30 h, the following morning (night)<br>2. Serum parathyroid hormone level, measured at baseline (0 hours) and 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 24.0 hours after<br>3. Serum FGF23 level, measured at baseline (0 hours) and 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 24.0 hours after